Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
- PMID: 9554361
- DOI: 10.1097/00005392-199805000-00050
Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
Abstract
Purpose: We demonstrate the effect of chronic inflammation of the prostate on the ratio of free-to-total prostate specific antigen (PSA) in serum calculated as a percentage of free PSA and, therefore, that percentage of free PSA is an unspecific means to distinguish among prostate cancer, chronic prostatitis and benign prostatic hyperplasia (BPH).
Materials and methods: Total, free and percentage of free PSA was measured in 66 men with prostate cancer, 119 with BPH and 17 with asymptomatic chronic prostatitis. In all patients the diagnosis was histopathologically confirmed by microscopic examination of prostatic specimens after sextant biopsy, transurethral prostatic resection or prostatectomy.
Results: The median values of total, free and percentage of free PSA were 4.11 microg./l., 0.75 microg./l. and 20.4% in patients with BPH, 10.0 microg./l., 0.84 microg./l. and 8.5% in those with prostate cancer, and 7.60 microg./l., 1.23 microg./l. and 10.6% in those with chronic prostatitis. Patients with prostate cancer and chronic prostatitis had a significantly lower percentage of free PSA than those with BPH. Receiver operating characteristics curve analysis showed that percentage of free PSA as a discriminator between prostate cancer and BPH was not suitable for differentiating between prostate cancer and chronic prostatitis.
Conclusions: Chronic prostatitis is not characterized by elevated total PSA concentrations alone but also by a decreased percentage of free PSA, a tendency similar to that in prostate cancer. This unspecific change in percentage of free PSA must be considered to interpret the percentage of free PSA correctly.
Similar articles
-
Effect of NIH-IV prostatitis on free and free-to-total PSA.Eur Urol. 2004 Dec;46(6):760-4. doi: 10.1016/j.eururo.2004.08.003. Eur Urol. 2004. PMID: 15548444
-
The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.J Urol. 1999 Nov;162(5):1587-90. J Urol. 1999. PMID: 10524873
-
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.J Urol. 1998 May;159(5):1599-605. doi: 10.1097/00005392-199805000-00051. J Urol. 1998. PMID: 9554362
-
The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.Andrologia. 2008 Apr;40(2):130-3. doi: 10.1111/j.1439-0272.2007.00820.x. Andrologia. 2008. PMID: 18336465 Review.
-
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis.Curr Urol Rep. 2009 Jul;10(4):302-6. doi: 10.1007/s11934-009-0049-0. Curr Urol Rep. 2009. PMID: 19570492 Review.
Cited by
-
The relationship between histological prostatitis and lower urinary tract symptoms and sexual function.Int Braz J Urol. 2016 May-Jun;42(3):540-5. doi: 10.1590/S1677-5538.IBJU.2015.0254. Int Braz J Urol. 2016. PMID: 27286118 Free PMC article.
-
Chronic immune activation and inflammation as the cause of malignancy.Br J Cancer. 2001 Aug 17;85(4):473-83. doi: 10.1054/bjoc.2001.1943. Br J Cancer. 2001. PMID: 11506482 Free PMC article. Review.
-
STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors.Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14523-8. doi: 10.1073/pnas.96.25.14523. Proc Natl Acad Sci U S A. 1999. PMID: 10588738 Free PMC article.
-
Systematic Differences Between Total and Free Prostate-Specific Antigen Immunoassays: Comparison Using Passing and Bablok Regression.Indian J Clin Biochem. 2021 Apr;36(2):151-158. doi: 10.1007/s12291-019-0818-6. Epub 2019 Feb 13. Indian J Clin Biochem. 2021. PMID: 33867705 Free PMC article.
-
Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA.Int Urol Nephrol. 1999;31(3):351-9. doi: 10.1023/a:1007178203861. Int Urol Nephrol. 1999. PMID: 10672955
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous